Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral Prophylaxis”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Post-approval studies (Phase 4)Looking for participantsNCT06958796
What this trial is testing

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Who this might be right for
CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more
Camille N. Kotton, MD 80
Testing effectiveness (Phase 2)Study completedNCT05507567
What this trial is testing

Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model

Who this might be right for
Influenza Viral Infections
Pneumagen Ltd. 104
Large-scale testing (Phase 3)Study completedNCT00784784
What this trial is testing

Zanamivir Versus Trivalent Split Virus Influenza Vaccine

Who this might be right for
Influenza
Mount Sinai Hospital, Canada 64
Not applicableLooking for participantsNCT07294547
What this trial is testing

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

Who this might be right for
Kidney Transplantation, Cytomegalovirus InfectionsEBV InfectionAntiviral Prophylaxis
National Taiwan University Hospital 80
Post-approval studies (Phase 4)Study completedNCT03619837
What this trial is testing

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Who this might be right for
Hepatitis CTransplantation Disease Transmission
University of California, San Francisco 122
Large-scale testing (Phase 3)Study completedNCT01580202
What this trial is testing

Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine

Who this might be right for
MalignancyHepatitis B
Seoul National University Hospital 180
Testing effectiveness (Phase 2)Study completedNCT00307151
What this trial is testing

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV

Who this might be right for
HIV Infections
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 452
Large-scale testing (Phase 3)Looking for participantsNCT07159763
What this trial is testing

Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza

Who this might be right for
Influenza
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 7,500
Large-scale testing (Phase 3)WithdrawnNCT02349828
What this trial is testing

Antiviral Prophylaxis in a Burn Population

Who this might be right for
Herpes Simplex
Southern Illinois University
Post-approval studies (Phase 4)Looking for participantsNCT06792214
What this trial is testing

Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

Who this might be right for
SARS CoV-2 Post-Acute Sequelae
Mount Sinai Hospital, Canada 118
Testing effectiveness (Phase 2)Study completedNCT05381454
What this trial is testing

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

Who this might be right for
Respiratory Viral InfectionAntiviral TreatmentCOVID-19
University of California, Los Angeles 80
Not applicableStudy completedNCT02538172
What this trial is testing

Cell-mediated Immunity for Prevention of CMV Disease

Who this might be right for
Cytomegalovirus Infections
University of Lausanne Hospitals 195
Post-approval studies (Phase 4)WithdrawnNCT03626376
What this trial is testing

Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis

Who this might be right for
Herpes Simplex Virus Keratitis
NYU Langone Health
Not applicableWithdrawnNCT00640874
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza

Who this might be right for
Pandemic Influenza
Kirby Institute
Post-approval studies (Phase 4)Not Yet RecruitingNCT07341386
What this trial is testing

Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases

Who this might be right for
Autoimmune Rheumatic DiseasesRecurrent Herpes SimplexPrevention
University of Sao Paulo General Hospital 62
Post-approval studies (Phase 4)Study completedNCT00304434
What this trial is testing

Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.

Who this might be right for
Influenza
US Department of Veterans Affairs 48
Early research (Phase 1)Study completedNCT00646152
What this trial is testing

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

Who this might be right for
InfluenzaSevere Acute Respiratory Distress SyndromeSmallpox+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 57
Large-scale testing (Phase 3)WithdrawnNCT04550338
What this trial is testing

Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure

Who this might be right for
COVID-19
University of Alabama at Birmingham
Post-approval studies (Phase 4)Study completedNCT01552369
What this trial is testing

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

Who this might be right for
Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 205
Testing effectiveness (Phase 2)Study completedNCT00334529
What this trial is testing

Alternative Oseltamivir Dosing Strategies

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 48
Load More Results